Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 533-538

  Goodman, Greg ^a,b  

^a SKIN AND CANCER FOUNDATION   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; HYALURONIDASE; IODINE; SODIUM CHLORIDE;

ARTICLE; AXILLA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DIFFUSION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MIXTURE; ENZYME ACTIVITY; FACE MUSCLE; FACE WRINKLING; FEMALE; FOREHEAD; GRAVIMETRY; HUMAN; HYPERHIDROSIS; IMAGE ANALYSIS; INJECTION SITE; LONGEVITY; MALE; MUSCLE CONTRACTURE; OUTCOMES RESEARCH; PHOTOGRAPHY; PILOT STUDY; PRIORITY JOURNAL;

AXILLA; BIOLOGICAL TRANSPORT; BOTULINUM TOXIN TYPE A; DIFFUSION; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG INTERACTIONS; FACE; HUMANS; HYALURONOGLUCOSAMINIDASE; HYPERHIDROSIS; NEUROMUSCULAR AGENTS; PILOT PROJECTS; SKIN AGING; TREATMENT OUTCOME;

EID: 0037610916     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29126.x     Document Type: Article

References (38)

1. Schiao G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-5.
2. Borodic GE, Pearce LB, Smith KL, Phelan M, Ferrante R. Botulinum B toxin as an alternative to botulinum A toxin: a histologic study. Ophthal Plast Reconstr Surg 1993;9:182-90.
3. Wall SA, Chait LA, Temlett JA, Perkins B, Hillen G, Becker P. Botulinum A chemodenervation: a new modality in cerebral palsied hands. Br J Plast Surg 1993;46:703-6.
4. Kristan RW, Stasior OG. Treatment of blepharospasm with high dose brow injection of botulinum toxin. Ophthal Plast Reconstr Surg 1987;3:25-7.
5. Biglan AW, May M, Bowers RA. Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum). Arch Otolaryngol Head Neck Surg 1988;114:1407-12.
6. Borodic GE, Mills L, Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg 1991;87:285-9.
7. Jost WH, Schimrigk K. Botulinum toxin in therapy of anal fissure. Lancet 1995;345:188-9.
8. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;332:774-8.
9. Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 1995;112:566-71.
10. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994;94:94-9.
11. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg 1994;93:913-8.
12. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993;119:1018-22.
13. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18: 17-21.
14. Carruthers A, Carruthers JD. Botulinum toxin in the treatment of glabella frown lines and other facial wrinkles. In: Jankovic J, Hallett M, eds. Therapy With Botulinum Toxin. New York: Marcel Dekker, 1994:577.
15. Kuttner C, Troger M, Dempf R, Eckardt A. Effectiveness of botulinum toxin A in the treatment of gustatory sweating [abstract]. Nervenarzt 2001;72:787-90.
16. Madsen JB, Illum P. Treatment of Frey syndrome with intracutaneous injections of botulinum toxin [abstract]. Ugeskr Laeger 2002;164:762-5.
17. Togel B, Greve B, Raulin C. Current therapeutic strategies for hyperhidrosis: a review. Eur J Dermatol 2002;12:219-23.
18. Naver H, Aquilonius S-M. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997;4(Suppl 2):S75-9.
19. Heckman M, Ceballos-Baumann AO, Plewig G. Botulinum toxin type A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-93.
20. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;323:596-9.
21. Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 2001;15:207-11.
22. Drott C, Gothberg G, Claes G. Endoscopic transthoracic sympathectomy: an efficient and safe method for the treatment of hyperhidrosis. J Am Acad Dermatol 1995;33:78-81.
23. Drott C, Claes G. Hyperhidrosis treated by thoracic sympathectomy. Cardiovasc Surg 1996;4:790-1.
24. Herbst F, Plas EG, Fugger R, Fritsch A. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs: a critical analysis and long-term results of 480 operations. Ann Surg 1994;220:86-90.
25. Lai YT, Yang LH, Chio CC, Chen HH. Complications in patients with palmar hyperhidrosis treated with transthoracic endoscopic sympathectomy. Neurosurgery 1997;41:110-3.
26. Hyaluronidase. In: McEvoy GK, eds. AHFS Drug Information 2001. Bethesda, MD: American Society of Health-Systems Pharmacists, 2001:2602-3.
27. Franklin MR. Enzymes. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy, 19th ed. Easton, PA: Mack Publishing, 1995:1137-9.
28. van den Berg AA, Montoya-Pelaez LF. Comparison of lignocaine 2% with adrenaline, bupivacaine 0.5% with or without hyaluronidase and a mixture of bupivacaine, lignocaine and hyaluronidase for peribulbar block analgesia. Acta Anaesthesiol Scand 2001;45:961-6.
29. Kallio H, Paloheimo M, Maunuksela EL. Hyaluronidase as an adjuvant in bupivacaine-lidocaine mixture for retrobulbar/peribulbar block. Anesth Analg 2000;91:934-7.
30. Jehan FS, Hagan JC III, Whittaker TJ, Subramanian M. Diplopia and ptosis following injection of local anesthesia without hyaluronidase. J Cataract Refract Surg 2001;27:1876-9.
31. Brown SM, Coats DK, Collins ML, Underdahl JP. Second cluster of strabismus cases after periocular anesthesia without hyaluronidase. J Cataract Refract Surg 2001;27:1872-5.
32. Mennuni C, Calvaruso F, Zampaglione I., et al. Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002;13:355-65.
33. Zimmet SE. Hyaluronidase in the prevention of sclerotherapy-induced extravasation necrosis: a dose-response study. Dermatol Surg 1996;22:73-6.
34. Zimmer SE. The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol 1993;19:641-6.
35. Cicchetti S, Jemec B, Gault DT. Two case reports of vinorelbine extravasation: management and review of the literature. Tumori 2000;86:289-92.
36. Khan MS, Holmes JD. Reducing the morbidity from extravasation injuries. Ann Plast Surg 2002;48:628-32.
37. Mullin S, Beckwith MC, Tyler LS. Prevention and management of antineoplastic extravasation injury. Hospital Pharm 2000;35:57-76.
38. Appendix G: guidelines for management of intravenous extravasations. In: Zenk KE, Sills JH, Koeppel RM. Neonatal Medications and Nutrition: A Comprehensive Guide. Santa Rosa, CA: NICU Ink, 1999:627-9.